Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies

Published:2024-08 Issue: Volume:245 Page:116185
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Zhao Xiang,Qian Weizhu,Hou Sheng,Wu Yimei,Guo Huaizu,Xu Jin,Zhang Dapeng,Li Jun,Fu Rongrong,Xu Mengjiao,Wang Fugui

Funder

Liaocheng University

Publisher

Elsevier BV

Reference34 articles.

1. Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer;Triantafyllidi;Biomedicines,2022

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients;Sun;Cancer Manag Res,2019

4. Anti-EGFR therapy: mechanism and advances in clinical efficacy in breast cancer;Flynn;J. Oncol. 2009,2009

5. Targeting the human epidermal growth factor receptor family in breast cancer beyond HER2;Riecke;Breast Care,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP